Diabetes
Applied Evidence
Treating type 2 diabetes: Targeting the causative factors
Original Research
Starting insulin in type 2 diabetes: Continue oral hypoglycemic agents?
A randomized trial in primary care
Commentary
Improving diabetics care
Clinical Inquiries
Does screening for diabetes in at-risk patients improve long-term outcomes?
EVIDENCE-BASED ANSWER: No randomized clinical trials or prospective studies have demonstrated adequate evidence to screen individuals for diabetes...
Clinical Inquiries
What is the best treatment for diabetic neuropathy?
EVIDENCE-BASED ANSWER: Tricyclic antidepressants, anticonvulsants, and capsaicin reduce the pain of diabetic neuropathy; limited data suggests...
Clinical Inquiries
Are ARBs or ACE inhibitors preferred for nephropathy in diabetes?
EVIDENCE-BASED ANSWER: Angiotensin receptor blockers (ARBs) have been shown to reduce the progression of nephropathy in several consistent studies...
Practice Alert
Type 2 diabetes: The role of basal insulin therapy
Q&A
Treatment of high LDL saves lives of those with diabetes or cardiovascular disease
BACKGROUND: It is recommended that patients with diabetes mellitus but without symptomatic cardiovascular disease should receive lipid-lowering...
Clinical Inquiries
Do ACE inhibitors prevent nephropathy in type 2 diabetes without proteinuria?
EVIDENCE-BASED ANSWER: Angiotensin-converting enzyme (ACE) inhibitors make a significant difference for patients with diabetes as a whole. If...
Q&A
Diet may slow progression of diabetic nephropathy
BACKGROUND: Patients with end-stage renal disease are usually encouraged to follow a low-protein diet to slow the progression of their renal...
Q&A
Do irbesartan and amlodipine reduce cardiovascular events in diabetic patients?
BACKGROUND: Good control of blood pressure reduces microvascular and macrovascular complications in patients with diabetes more than control of...